News

Check all IrsiCaixa scientific news in just one click.

ciclodextrina farmaco sarscov2

SARS-CoV-2

Therapies

26/06/2023

Drug prevents infection with SARS-CoV-2 and other coronaviruses in preclinical models

Microbiome

08/06/2023

Mental and gut health, closely linked by the microbiome

Vacuna VIH

HIV

Vaccines

03/05/2023

IrsiCaixa designs HIV-like particles that induce an effective immune response in preclinical studies

Siglec1 VIH IrsiCaixa

HIV

13/04/2023

New insights on the early stages of HIV infection in the human body

SARS-CoV-2

Vaccines

31/03/2023

HIPRA's COVID-19 vaccine, developed with the scientific support of IrsiCaixa, receives a positive opinion from the European Medicines Agency

PREP ITS tractament

HIV

PrEP

30/03/2023

More accessible PrEP to promote HIV prevention in Spain

Coronavirus

SARS-CoV-2

29/03/2023

3 years of COVID-19: from emergency research to a consolidated study area

entrega subvencions

Post COVID-19

20/03/2023

IrsiCaixa receives a grant from Barcelona City Council to study long COVID in children

Organoids

07/03/2023

Creation of the first biobank of farm animal organoids in Spain based on a project with the participation of IrsiCaixa